Spotfire, Accelrys, and The BioTeam Join SciTegic's ISV Program; Part

    Business Editors/Biotech Writers/Science Writers
    BIOWIRE2K

    SAN DIEGO, Calif.--(BUSINESS WIRE)--May 5, 2005--SciTegic announced today that Spotfire, Inc., Accelrys, Inc., and The BioTeam have joined its independent software vendor (ISV) partner program in order to utilize Pipeline Pilot to integrate their industry-leading products.
    Spotfire is developing an interface to launch Pipeline Pilot data processing workflows from within DecisionSite, its visual data analytics application. Accelrys software users will gain the ability to add more information about their data (e.g., derived chemical properties) through the execution of data processing routines via Pipeline Pilot. Through its professional services consulting, The BioTeam will now be able to help life science researchers develop infrastructures that integrate Pipeline Pilot. These industry leaders join the six other software vendors that have recently joined the ISV program.
    Spotfire and SciTegic's collaboration will help tightly couple DecisionSite's easy-to-use, interactive visual analytics with the powerful, automated data processing features of Pipeline Pilot. The integration uses DecisionSite's open computational services framework to allow researchers to easily embed Pipeline Pilot computations and data pipelining methods in DecisionSite Guides.
    Accelrys has begun integrating a number of applications in the areas of chemical informatics and visualization, structure based design, and bioinformatics. One of the first advances will allow users of DS Accord for Excel to call computational protocols within Pipeline Pilot. Furthermore, Pipeline Pilot users will be able to access DS Accord Chemistry Cartridge databases in Oracle and to automate and deploy high-throughput docking experiments and consensus scoring using Accelrys' LigandFit and LigScore.
    "SciTegic recently launched its ISV program to provide a level-playing field for software vendors that want to integrate their tools in a data pipelining environment. We provide technical assistance to help our partners achieve high quality integration." commented Matt Hahn, vice-president & general manager of SciTegic. "Combining the tools from these ISVs with Pipeline Pilot will allow our customers to solve more complex problems, and do it in a more efficient manner."
    "We are responding to the needs of our customers, including leading pharmaceutical R&D organizations that see great value in integrating these products," commented Spotfire President Rock Gnatovich. "Bringing together the data processing workflow of Pipeline Pilot with the analysis workflow capabilities of DecisionSite will solve a key business problem for researchers-shortening the time to the next experiment in the discovery process."
    "Building a strong set of technologies around Pipeline Pilot is an essential element to providing our customers with effective scientific solutions, said Mark Emkjer, president & CEO of Accelrys. "We believe our customers will get more flexibility and choice and see tremendous benefits by being able to operate Accelrys' scientific applications within SciTegic's data pipelining framework."
    "The BioTeam's strength is building scalable informatics solutions for life sciences," said William Van Etten, PhD, Founding Partner of The BioTeam. "Our partnership with SciTegic will further strengthen our capability to provide a comprehensive solution to our customers."

    About SciTegic

    SciTegic, a wholly owned subsidiary of Accelrys, Inc. (NASDAQ:ACCL), develops and markets informatics software to the pharmaceutical and biotechnology industries. SciTegic has pioneered a technology approach called "Data Pipelining" to process drug discovery data with unprecedented flexibility. This methodology has established its utility by accelerating informatics research for thousands of users at hundreds of customer sites worldwide. Further information about SciTegic is available at: www.scitegic.com.

    About Spotfire

    Spotfire, Inc. provides interactive, visual data analytics applications and services that empower enterprises and their end-users to improve operational performance and gain an information advantage over the competition. Over 25,000 users in close to 1,000 organizations around the world use Spotfire DecisionSite to drive confident decision-making by quickly and easily spotting trends, outliers and unanticipated relationships in critical business data. The company maintains U.S. headquarters in Somerville, MA, and European headquarters in Goteborg, Sweden. Additional information can be found at: www.spotfire.com.

    About Accelrys

    Accelrys, Inc. (NASDAQ:ACCL) is a leading provider of software for computation, simulation, and the management and mining of scientific data used by biologists, chemists and materials scientists, including nanotechnology researchers for product design as well as drug discovery and development. Accelrys technology and services are designed to meet the needs of today's leading research organizations. The company is headquartered in San Diego, California. For more information about Accelrys, visit its website at http://www.accelrys.com/.

    About The BioTeam

    The BioTeam is a consulting collective dedicated to delivering vendor-neutral informatics solutions to the life science industry. The BioTeam provides complete beginning-to-end life science informatics and Bio-IT solutions and has proven success at bridging the Science-IT gap. For more information visit: www.bioteam.net.

    This press release contains forward-looking statements for the purpose of the Private Securities Litigation Act of 1995 ("the Act"). When used anywhere in this document, the words "expects," "believes," "anticipates," "estimates," and similar expressions are intended to identify forward-looking statements. Examples of forward-looking statements herein include statements regarding future success of the SciTegic ISV program, and of benefits realized from integration of SciTegic products with Accelrys', Spotfire's and The BioTeam's products and services. Accelrys and SciTegic have based these forward-looking statements on their current expectations about future events. Such statements are subject to risks and uncertainties including, but not limited to, the risk that the program will not be successful and the products will not be successfully developed, integrated or achieve market acceptance, as well as other risks described in Accelrys' filings with the Securities and Exchange Commission, including its most recent report on Form 10-Q. All forward-looking statements in this document are qualified entirely by the cautionary statements included in this document and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this document. These forward-looking statements speak only as of the date of this document. Accelrys claims the protection of the safe-harbor for forward -looking statements in the Act, and disclaims any intent or obligation to publicly update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

--30--MR/la*

CONTACT: Accelrys, Inc Ian Clements, 858-799-5440 iclements@accelrys.com or SciTegic, Inc Marty Kleine, 858-279-8800 mkleine@scitegic.com

KEYWORD: CALIFORNIA INDUSTRY KEYWORD: HARDWARE ADVERTISING/MARKETING BIOTECHNOLOGY SOFTWARE MARKETING AGREEMENTS SOURCE: Accelrys, Inc.

Copyright Business Wire 2005